Alison Moore - Net Worth and Insider Trading
Alison Moore Net Worth
The estimated net worth of Alison Moore is at least $174,624 dollars as of 2025-04-13. Alison Moore is the Chief Technical Officer of Allogene Therapeutics Inc and owns about 120,430 shares of Allogene Therapeutics Inc (ALLO) stock worth over $174,624. Details can be seen in Alison Moore's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alison Moore has not made any transactions after 2022-03-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alison Moore
Alison Moore Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alison Moore owns 2 companies in total, including Allogene Therapeutics Inc (ALLO) , and Codexis Inc (CDXS) .
Click here to see the complete history of Alison Moore’s form 4 insider trades.
Insider Ownership Summary of Alison Moore
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALLO | Allogene Therapeutics Inc | 2022-03-15 | Chief Technical Officer |
| CDXS | Codexis Inc | 2020-06-16 | director |
Alison Moore Latest Holdings Summary
Alison Moore currently owns a total of 1 stock. Alison Moore owns 120,430 shares of Allogene Therapeutics Inc (ALLO) as of March 15, 2022, with a value of $174,624.
Latest Holdings of Alison Moore
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics Inc | 2022-03-15 | 120,430 | 1.45 | 174,624 |
Holding Weightings of Alison Moore
Alison Moore Form 4 Trading Tracker
According to the SEC Form 4 filings, Alison Moore has made a total of 5 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Allogene Therapeutics Inc is the sale of 8,698 shares on March 15, 2022, which brought Alison Moore around $66,366.
Insider Trading History of Alison Moore
- 1
Alison Moore Trading Performance
Alison Moore Ownership Network
Ownership Network List of Alison Moore
Ownership Network Relation of Alison Moore
Alison Moore Owned Company Details
What does Allogene Therapeutics Inc do?
Who are the key executives at Allogene Therapeutics Inc?
Alison Moore is the Chief Technical Officer of Allogene Therapeutics Inc. Other key executives at Allogene Therapeutics Inc include director & President and CEO David D Chang , GENERAL COUNSEL Earl Martin Douglas , and CHIEF FINANCIAL OFFICER Geoffrey M. Parker .
Allogene Therapeutics Inc (ALLO) Insider Trades Summary
Over the past 18 months, Alison Moore made no insider transaction in Allogene Therapeutics Inc (ALLO). Other recent insider transactions involving Allogene Therapeutics Inc (ALLO) include a net sale of 59,730 shares made by Deborah M. Messemer , a net sale of 92,671 shares made by David D Chang , and a net sale of 46,031 shares made by Zachary Roberts .
In summary, during the past 3 months, insiders sold 183,014 shares of Allogene Therapeutics Inc (ALLO) in total and bought 0 shares, with a net sale of 183,014 shares. During the past 18 months, 249,852 shares of Allogene Therapeutics Inc (ALLO) were sold and 1,724,327 shares were bought by its insiders, resulting in a net purchase of 1,474,475 shares.
Allogene Therapeutics Inc (ALLO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Allogene Therapeutics Inc Insider Transactions
Alison Moore Mailing Address
Above is the net worth, insider trading, and ownership report for Alison Moore. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Alison Moore's mailing address is: South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
